Prevalence of the aminoglycoside phosphotransferase genes aph(39)-IIIa and aph(39)-IIa in Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Pseudomonas aeruginosa, Salmonella enterica subsp. Enterica and Staphylococcus aureus isolates in Austria

Journal of Medical Microbiology

Volumn 63, Issue PART 2, 2014, Pages 210-217

  Woegerbauer, Markus ^a   Zeinzinger, Josef ^a   Springer, Burkhard ^a   Hufnagl, Peter ^a   Indra, Alexander ^a   Korschineck, Irina ^b   Hofrichter, Johannes ^a   Kopacka, Ian ^a   Fuchs, Reinhard ^a   Steinwider, John ^a   Fuchs, Klemens ^a   Nielsen, Kaare M ^c   Allerberger, Franz ^a  

^a AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^b University of Tromsø ^*

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; AUSTRIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; ESCHERICHIA COLI; GENE POOL; GENE SEQUENCE; GENETIC RESISTANCE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; AUSTRIA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KANAMYCIN KINASE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84892994962     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.065789-0     Document Type: Article

References (40)

1. Apfalter, P., Fluch, P., Metz-Gercek, S. & Allerberger, F. (2012).̈ Resistenzbericht Österreich AURES 2011 - Antibiotikaresistenz und Verbrauch antimikrobieller Substanzen in Österreich (Antibiotic esistance rates and antibiotic consumption in Austria). Federal ministry of Health, Vienna.
2. Beck, E., Ludwig, G., Auerswald, E. A., Reiss, B. & Schaller, H. (1982). Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 19, 327-336.
3. Becker, B. & Cooper, M. A. (2013). Aminoglycoside antibiotics in the 21st century. ACS Chem Biol 8, 105-115.
4. Brown, L. D., Cai, T. T. & DasGupta, A. (2001). Interval estimation for a binomial proportion. Stat Sci 16, 101-133.
5. CLSI (2009). Performance Standards for Antimicrobial Susceptibility Testing; 19th informational supplement M100-S19. Villanova, PA, USA: Clinical and Laboratory Standards Institute.
6. Derbise, A., Aubert, S. & El Solh, N. (1997). Mapping the regions carrying the three contiguous antibiotic resistance genes aadE, sat4, and aphA-3 in the genomes of staphylococci. Antimicrob Agents Chemother 41, 1024-1032.
7. Dubois, V., Arpin, C., Dupart, V., Scavelli, A., Coulange, L., André, C., Fischer, I., Grobost, F., Brochet, J.-P. & other authors (2008). B-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother 62, 316-323.
8. Durante-Mangoni, E., Grammatikos, A., Utili, R. & Falagas, M. E. (2009). Do we still need the aminoglycosides? Int J Antimicrob Agents 33, 201-205.
9. ECDC (2012). European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net), Stockholm.
10. EUCAST (2013). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. European Committee on Antimicrobial Susceptibility Testing.
11. Fong, D. H. & Berghuis, A. M. (2002). Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J 21, 2323-2331.
12. Fuchs, K. (2012). European surveillance of veterinary consumption (ESVAC). In Resistenzbericht Österreich AURES 2011 - Antibioikaresistenz und Verbrauch antimikrobieller Substanzen in Österreich Antibiotic Resistance Rates and Antibiotic Consumption in Austria, pp. 316-319. Edited by P. Apfalter, P. Fluch, S. Metz-Gercek & F. Allerberger.
13. Gibreel, A., Sköld, O. & Taylor, D. E. (2004). Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni. Microb Drug Resist 10, 98-105.
14. Health Protection Agency (2007). Kauffmann-White Scheme - 2007: Salmonella identification - serotypes and antigenic formulae.
15. Jia, X., Zhang, J., Sun, W., He, W., Jiang, H., Chen, D. & Murchie, A. I. (2013). Riboswitch control of aminoglycoside antibiotic resistance. Cell 152, 68-81.
16. Kim, J.-Y., Park, Y.-J., Kwon, H. J., Han, K., Kang, M. W. & Woo, G.-J. (2008). Occurrence and mechanisms of amikacin resistance and its association with b-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother 62, 479-483.
17. Kozak, M. (2005). Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361, 13-37.
18. Leclercq, R., Cantón, R., Brown, D. F., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C. & other authors (2013). EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19, 141-160.
19. Leff, L. G., Dana, J. R., McArthur, J. V. & Shimkets, L. J. (1993). Detection of Tn5-like sequences in kanamycin-resistant stream bacteria and environmental DNA. Appl Environ Microbiol 59, 417-421.
20. Leibovici, L., Vidal, L. & Paul, M. (2009). Aminoglycoside drugs in clinical practice: an evidence-based approach. J Antimicrob Chemother 63, 246-251.
21. Ma, B. L., Blackshaw, R. E., Roy, J. & He, T. (2011). Investigation on gene transfer from genetically modified corn (Zea mays L.) plants to soil bacteria. J Environ Sci Health B 46, 590-599.
22. Magnet, S. & Blanchard, J. S. (2005). Molecular insights into aminoglycoside action and resistance. Chem Rev 105, 477-498.
23. ÖGACH (2012). Österreichische Gesellschaft für Antimikrobielle Chemotherapie: Antiinfektiva.
24. Peirano, G., Agersø, Y., Aarestrup, F. M., dos Reis, E. M. & dos Prazeres Rodrigues, D. (2006). Occurrence of integrons and antimicrobial resistance genes among Salmonella enterica from Brazil. J Antimicrob Chemother 58, 305-309.
25. Perlin, M. H. & Lerner, S. A. (1986). High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake. Antimicrob Agents Chemother 29, 216-224.
26. Picard, F., Dressaire, C., Girbal, L. & Cocaign-Bousquet, M. (2009). Examination of post-transcriptional regulations in prokaryotes by integrative biology. C R Biol 332, 958-973.
27. Ramirez, M. S. & Tolmasky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resist Updat 13, 151-171.
28. Rosellini, D. (2012). Selectable markers and reporter genes: a well furnished toolbox for plant science and genetic engineering. Crit Rev Plant Sci 31, 401-453.
29. Schmieder, R. & Edwards, R. (2012). Insights into antibiotic resistance through metagenomic approaches. Future Microbiol 7, 73-89.
30. Schmitz, F.-J., Fluit, A. C., Gondolf, M., Beyrau, R., Lindenlauf, E., Verhoef, J., Heinz, H.-P. & Jones, M. E. (1999). The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother 43, 253-259.
31. Shaw, K. J., Rather, P. N., Hare, R. S. & Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57, 138-163.
32. Smalla, K., Van Overbeek, L. S., Pukall, R. & Van Elsas, J. D. (1993). The prevalence of nptII and Tn5 in kanamycin-resistant bacteria from different environments. FEMS Microbiol Lett 13, 47-58.
33. Thomas, C. M. & Nielsen, K. M. (2005). Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat Rev Microbiol 3, 711-721.
34. Trieu-Cuot, P. & Courvalin, P. (1983). Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3950-aminoglycoside phosphotransferase type III. Gene 23, 331-341.
35. WHO (2011). Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update.
36. WHO (2012). Critically important antimicrobials for human medicine, 3rd revision 2011. WHO Press, World Health Organization, Geneva.
37. Wright, G. D. & Thompson, P. R. (1999). Aminoglycoside phospho-transferases: proteins, structure, and mechanism. Front Biosci 4, D9-D21.
38. Yuan, W., Hu, Q., Cheng, H., Shang, W., Liu, N., Hua, Z., Zhu, J., Hu, Z., Yuan, J. & other authors (2013). Cell wall thickening is associated with adaptive resistance to amikacin in methicillin-resistant Staphylococcus aureus clinical isolates. J Antimicrob Chemother 68, 1089-1096.
39. Zarrilli, R., Tripodi, M.-F., Di Popolo, A., Fortunato, R., Bagattini, M., Crispino, M., Florio, A., Triassi, M. & Utili, R. (2005). Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. J Antimicrob Chemother 56, 827-835.
40. Zhu, B. (2007). Abundance dynamics and sequence variation of neomycin phosphotransferase gene (nptII) homologs in river water. Aquat Microb Ecol 48, 131-140.